Robeauté Overview
- Year Founded
-
2017

- Status
-
Private
- Employees
-
30

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$28M
- Investors
-
12
Robeauté General Information
Description
Developer of a sub-millimetric medical device designed to diagnose and treat neuropathologies. The company's device is a nanobot that is smaller than a human cell that can enter the brain, navigate through tissues and cells and reach the targeted area without causing trauma, while the nanoelectronics included in the device lets it send critical information back to neuroscientists, enabling neurologists to get a device that can reach the human brain to treat neurological diseases and brain tumors.
Contact Information
Website
www.robeaute.comCorporate Office
- 9 Boulevard Montmartre
- 75002 Paris
- France
Corporate Office
- 9 Boulevard Montmartre
- 75002 Paris
- France
Robeauté Timeline
Robeauté Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series A) | 14-Jan-2025 | $28M | Completed | Generating Revenue | ||
4. Accelerator/Incubator | 29-May-2024 | Completed | Generating Revenue | |||
3. Later Stage VC | 22-Jan-2022 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 02-Jun-2020 | $54.6K | $1.26M | Completed | Pre-Clinical Trials | |
1. Seed Round | 20-Mar-2018 | $1.21M | $1.21M | Completed | Pre-Clinical Trials |
Robeauté Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed Shares | ||||||||
Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Robeauté Patents
Robeauté Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4389051-A1 | Nose dive microrobot | Pending | 22-Dec-2022 | ||
EP-4382070-A1 | Resonating system - the limp | Pending | 09-Dec-2022 | ||
EP-4289366-A1 | Tracking system for 3d transcranial tracking of a medical device | Pending | 10-Jun-2022 | ||
EP-4536093-A1 | Tracking system for 3d transcranial tracking of a medical device | Pending | 10-Jun-2022 | ||
EP-4362838-A1 | Light propulsion for microrobot | Pending | 30-Jun-2021 | A61B34/37 |
Robeauté Signals
Robeauté Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Brainlab | PE-Backed Company | Minority | ||
Cherry Ventures | Venture Capital | Minority | ||
Kindred Ventures | Venture Capital | Minority | ||
Phoenix Court | Venture Capital | Minority | ||
Plural Platform | Venture Capital | Minority |
Robeauté FAQs
-
When was Robeauté founded?
Robeauté was founded in 2017.
-
Where is Robeauté headquartered?
Robeauté is headquartered in Paris, France.
-
What is the size of Robeauté?
Robeauté has 30 total employees.
-
What industry is Robeauté in?
Robeauté’s primary industry is Surgical Devices.
-
Is Robeauté a private or public company?
Robeauté is a Private company.
-
What is Robeauté’s current revenue?
The current revenue for Robeauté is
. -
How much funding has Robeauté raised over time?
Robeauté has raised $32.5M.
-
Who are Robeauté’s investors?
Brainlab, Cherry Ventures, Kindred Ventures, Phoenix Court, and Plural Platform are 5 of 12 investors who have invested in Robeauté.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »